Document is current
Any future updates will be listed below
-
Authors
Gaillet, Antoine https://orcid.org/0000-0003-0742-2348
Azoulay, Elie
de Montmollin, Etienne
Ruckly, Stéphane
Timsit, Jean-Francois
,
Garrouste- Orgeas, Maité
Cohen, Yves
Dupuis, Claire
Schwebel, Carole
Reignier, Jean
Siami, Shidasp
Argaud, Laurent
Adrie, Christophe
Mourvillier, Bruno
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 23 June 2024
First Online: 29 July 2024
Declarations
:
: EA reports fees for lectures from Gilead, Pfizer, Baxter, and Alexion. His research group has been supported by Ablynx, Fisher & Payckle, Jazz Pharma, and MSD. JFT reports membership of advisory boards: Pfizer, Gilead, Merck, BD France, Shionogi. His research group has been supported by Merck, Thermofischer, Pfizer. All these conflicts of interest are outside the present work. The other Authors declare no conflicts of interest.
: The OutcomeRea<sup>™</sup> database was declared to the “Comité consultatif français de l'informatique pour la recherche en santé” (CCTIRS) et la “Commission française de l'informatique et des libertés” (CNIL, #8999262), in accordance with French law, and this study was approved by the ethical committee of the French Society of Intensive Care (SRLF). Waiver for informed consent was granted because the study does not modify patients’ management and the data are anonymously collected.
